Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5326_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
52 Мб
Скачать
Fluoride conversion coatings for magnesium and its alloys for the biological environment 13
MgF
MgF
MgF
2ðsÞ
2ðsÞ
2ðsÞ
2þ
/Mg
ðaqÞ
þ 2Cl
þ 2NaCl
 ðaqÞ
þ 2F
ðaqÞ
/MgCl
/MgCl
ðsÞ
; DrG¼þ57:8kJ=mol (1.4)
2ðsÞ
þ 2F
2ðsÞ
; DrG¼þ183:2kJ=mol (1.5)
ðaqÞ
þ 2NaF
; DrG¼þ159:6kJ=mol (1.6)
ðsÞ
The short-term protection provided by the HF treatment attracted the attention of some researchers to its potential as a pretreatment step instead of a nal corrosion pro­tection process. As the defects on the MgF
layer can be covered by a sealant, the liter-
2
ature reports the deposition of different coatings on an HF-treated magnesium sample. For instance, Conceiç~ao et al. (2010), Conceiç~ao et al. (2011a,b), and Conceiç~ao,
Scharnagl, Dietzel, and Kainer (2012) have shown that polymer coatings on
HF-treated magnesium substrates behave much better than on the subst rates with other kinds of pretreatments. Such observation was made for different polymers such as pol­yetherimide (PEI), polyacrilonitrile (PAN), and polyvinylidene diuoride (PVDF). For these polymers, superior corrosion performance was observed in comparison with ground, as-received, and acid-etched samples (acetic and n itric acids) in electrochem­ical and immersion tests.
Figure 1.3 shows images of AZ31 samples after immersion tests. The samples
where PEI was coated were either pretreated with HF (14 mol/L and 20 mol/L) or ground. Both samples pretreated with HF show fewer signals of corrosion after a longer immersion time in the corrosive solution than the ground and as-received sam­ples. It can be observed that the grinding process considerably decreased the corrosion attack on the sample surface (compare the aspect of the ground and as-received sam­ple); however, one can observe coating delamination on the lower edge of the sample.
Figure 1.3 Image of AZ31 sheets coated with PEI (thickness of 15 mm), with different pretreatments, after immersion on 3.5 wt% NaCl at room temperature. From left to right: as-received (2 days of immersion), ground (2 days of immersion), 14 mol/L HF for 24 h (7 days of immersion), and 20 mol/L HF for 24 h (7 days of immersion). Reprinted with permission from Conceiç~ao et al. (2010).
14 Surface Modication of Magnesium and its Alloys for Biomedical Applications
For both coatings pretreated with HF no delamination was observed even after 7 days of immersion in the solution. These results indicate an improvement in adhesion pro­duced by the formed MgF
2
layer.
Such adhesion improvement allows self-healing processes to take place at the inter­face of an HF-treated/polymer-coated sample, as conrmed by X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy (FTIR) analysis (Conceiç~ao et al., 2010, 2011b, 2012). These self-healing processes produce imped- ance increases after a certain exposure time to the corrosive solution. In general, these processes were related to reactions between the corrosion product (magnesium hy­droxide) and the polymer. Such reactions resulted in polar groups attached to the poly­mer, at the interface, and in some cases in the formation of carboxylic acid groups. This allows acidebase interactions to take place at the interface, stabilizing the system. For PVDF, PEI, and PAN coatings on AZ31 sheets pretreated with HF, a stable impedance was observed for more than 1000 h of exposure to a 3.5 wt% NaCl solution (Conceiç~ao et al., 2010, 2011a,b, 2012).
1.3.2 Corrosion in simulated body uids and interaction with
biomolecules
Different studies in the literature report the inuence of MgF2coating on magnesium samples in simulated body uids. These uids simulate the ionic composition of the body, and the composition of some of these is shown in Table 1.3. The measurements are usually performed at 37 human body. Chiu et al. (2007) investigated the corrosion performance of pure mag­nesium ingots treated with HF in Hanks solution. It was observed that the corrosion current density was signicantly decreased by the HF treatment, while the impedance increased by 1 decade. Immersion tests corroborate the better corrosion resistance for
C and at a pH of 7.4 to better mimic the conditions of the
Table 1.3 Composition of simulated body uids (SBF) commonly
reported in the literature
SBF Composition (10L3mol/L)
Hanks solution
(Chiu et al., 2007)
NaCl (137), CaCl
NaHCO
3
MgCl
$6H2O (0.49), Na2HPO4$2H2O
2
(0.34), KH MgSO
$7H2O (0.26)
4
Kokubo solution
(Kokubo & Takadama, 2006)
þ
Na
(142.0), Kþ(5.0), Mg2þ(1.5), Ca (2.5), Cl(147.8), HCO (1.0), SO
Mao et al. (2013) NaCl (116), CaCl
MgSO
(0,83), NaHCO3(26), Na2HPO
4
(0.89), NaH2PO4(0.22)
(1.26), KCl (5.37),
2
(4.17), glucose (5.56),
(0.44),
2PO4
(4.2), HPO
2
(0.5)
4
2
3
(1.80), KCl (5.37),
2þ
2 4
4
Fluoride conversion coatings for magnesium and its alloys for the biological environment 15
the coated sample, in comparison to the uncoated one. Li et al. (2013) report the behavior of MgF
-coated Mg-1Ca alloy (the coating was deposited by physical vapor
2
deposition and had a reported thickness of 0.95 mm) in Hanks solution. The protec­tiveness provided by the coating was evaluated by means of electrochemical tech­niques, hydrogen evolution, and pH evaluation. It was reported that anodic and cathodic currents were considerably decreased by the coating, and the corrosion cur­rent density fell by half. Considerable decrease in the hydrogen gas evolution and pH increase was observed in time periods from 250 to 500 h.
Hanks solution was also used by Mao, Yuan, Niu, Zong, and Ding (2013), who
investigated the performance of the alloy JDBM coated with MgF
by means of
2
immersion in HF. The corrosion rate, obtained by gravimetric analysis, falls from
0.337 mm/y to 0.253 mm/y by treating with 40% HF for 12 h. Electrochemical imped­ance spectroscopy showed the expected increase in impedance, related to the appear­ance of a second semicircle in the Nyquist plot, and the direct polarization conrmed the results from the gravimetric analyses, showing a lower corrosion current density for the coated sample. Similar results are reported by different authors in other simu­lated body uids as Kokubo solutions (for example, Bakhsheshi-Rad et al., 2013). It is clear from the results in the literature that coating magnesium and its alloys with MgF either by immersion in HF or by other methods, improves the corrosion resistance in
3.5 wt% NaCl and simulated body uid. The performance of magnesium samples pretreated with HF and postcoated with
polymers on SBF is scarce in the literature. In the study of Conceiç~ao et al. (2012) it was shown that the performance of AZ31 sheets pretreated with HF and postcoated with PAN was inferior in SBF in comparison to a 3.5 wt% NaCl solution. On the one hand, the lower chloride concentration of the SBF makes it less aggressive to the m etal, b ut on the other hand, it produces a lower osmotic pressure. The water at the polymer/metal interface experiences a lower osmotic pressure toward the so­lution in SBF in comparison to 3.5 wt% NaCl solution, and therefore, the water can more easily diffuse through the coating. Figure 1.4 compares these samples after
,
2
Figure 1.4 Image of AZ31 sheets coated with PAN (thickness of 8 mm), pretreated with 14 mol/L HF (room temperature and 24 h) after one week of immersion in SBF (left) and
3.5wt% NaCl. The test in SBF was performed at 37
was performed at 25
C.
C while in the other solution the test
16 Surface Modication of Magnesium and its Alloys for Biomedical Applications
immersion tests, where it can be seen that the more intense corrosion attack took place in the SBF. Besides the effect of osmotic pressure, the higher temperature of the test performed in SBF also played an important role in the sample performance.
The literature also reports the biocompatibility of MgF
coated magnesium sam-
2
ples in vitro. Tests of cytotoxicity, hemolysis, and antibiolm properties are usually performed to investigate the interaction of the uoride coating in the presence of cells and biological molecules. Experiments of cell adhesion generally show that magnesium uoride coating signicantly decreases cytotoxicity in comparison to the uncoated alloy. For instance, Li et al. (2013) report the adherence of human osteosarcoma cells (MG63) and of mouse osteoblast-like cells (MC3T3-E1) on Mg-1Ca alloy coated and uncoated with MgF
(0.9 mm of thickness) during 72 h
2
of culture. It was observed that the coated samples had many more cells adhered to their surface than the uncoated ones. The few cells present on the uncoated sample were unhealthy, which according to the authors was related to the attack of magne­sium hydroxide. As the coated sample had a lower corrosion attack in the culture medium, the cell adhesion was higher. Similar results are reported by Drynda
et al. (2010) for smooth muscle cells on Mg-Ca alloys of different compositions.
The coatings (thicknesses ranging from 0.5 to 20 mm) provide considerable decrease in corrosion on the cultivation medium, and after 240 h, the cell viability was very high (ranging from 70e90%).
For endothelial cells, however, the MgF
coating shows considerable toxicity. In
2
the study of Drynda et al. (2010), the viability for this kind of cell was below 5% for all tested samples. In the study of Mao et al. (2013) on the cytotoxicity of JDBM alloys coated with MgF
(1.5 mm of thickness) toward endothelial cells, it
2
was observed that the coating decreased the cell viability in comparison to uncoated samples. Nevertheless, according to the authors, the performance of both coated and uncoated samples was compatible to the requirements for cell application. In this study it is also shown that MgF
-coated JDBM has a high hemolysis rate on blood tests,
2
which is a measure of how the implant reacts with blood constituents. The obtained rate is way above the maximum required for biological applications (10.1% when the required rate is 5%).
Another important requirem ent f or a biome dica l im pl ant is its a nt ibiolm prop­erties. Here, biolmrefers to bacterial communities on a self-made polymer ma­trix. According to studies in the literature, the occurrence of biolm is responsible for many cases of infections on the implanted area (Coster ton, Stewart, &
Greenberg, 1999; Darouiche, 2004). As these lms are usually resistant to antibi-
otics, a coating on biomedical implants must possess good antibiolm properties.
Lellouche et al. (2009, 2012) report an interesting result on the effect of MgF
nanoparticles on Escherichia coli and Staphylococcus aureus growth. It was shown that the nanoparticles effectively hindered the bacteria proliferation on coated glass substrates. According to the authors, the bacteria-killing property was related to the ability of the nano-sized MgF
Mao et al. (2013),itisshownthatMgF
particles to penetrate the bacteria. In the study of
2
coatings also have good antiplatelet
2
properties.
2
Fluoride conversion coatings for magnesium and its alloys for the biological environment 17
1.3.3 Corrosion in vivo
While the literature shows different studies on the corrosion performance of MgF
-coated magnesium samples in vitro, only a few studies report tests in vivo.
2
However, such tests are of great relevance considering the dynamic nature of biolog­ical environments, which may induce corrosion processes very distinct from those observed in vitro. Besides the problem of early implant failure, the corrosion of magnesium implants presents two main problems: hydrogen production and alkaliza­tion. A too high hydrogen production may cause subcutaneous cavities with potential postoperative inammation. The surface alkalinization of the implant, as mentioned above, may damag e the cells neighboring the implant, causing different adverse effects (Virtanen, 2011).
Most of these studies on MgF plantation in rabbit bones (femur and tibiae) with a focus on orthopedic applications. Only one study reported a subcutaneous implantation in mice, considering the potential of applicati on as stents. All of these studies show that the coating could effectively decrease the corrosion rate without signicant adverse effects. For instance, Sun et al. (2013) investigated the performance of Mg-3Zn-0.8Zr rods, coated with MgF
(0.5 mmofthickness),implantedinthefemurofwhiterabbits.Un-
2
coated samples and samples coated with calcium phosphates were used for compar­ison purposes. Gas cavities were not observed in any case; however, after 3 months of implantation, the sample coated with MgF and volume loss (see Figure 1.5). Further, the MgF adhered to it after 3 months, in comparison to the other samples. Micro-computed to­mography indicate d that the uoride-coated surface enhanced new bone growth, and that the bone trabecula formed on the surface of the uoride-coated alloy was in much better condition in comparison to the control groups. No adverse effect of alloy and MgF
degradation w as observed.
2
Similar observations were made by Witte et al. (2010) and Thomann et al. (2009) for the alloys LAE442 and MgCa0.8 implanted in the femur and tibiae of white rabbits, respectively. In the study of Witte et al. (2010), no blood alterations were detected in the follow-up analysis. However, some irritation was observed and attributed to the dissolution of MgF
. According to the authors, this might be related to the very
2
high thickness of the applied coating (150e200 mm). The coating considerably increased the corrosion protection. In the study of Thomann et al. (2009), very similar results were obtained in regard to corrosion rate and biocompatibility. Nevertheless, the authors mentioned that the coated magnesium alloy had lower mechanical proper­ties during the implantation time, compared to other studies in the literature. The pos­itive inuence of MgF
in in vivo tests was also reported by Drynda, Seibt, Hassel,
2
Bach, and Peuster (2013) on the study of MgF
ously implanted in mice.
These results show that the use of HF treatment is an effective way of increasing corrosion resistance of magnesium alloy implants in biological environments. In all cases, superior corrosion resistance was observed for MgF only a few adverse effects. However, more investigations are required to assure that
-coated magnesium implants in vivo perform im-
2
showed much lower corrosion attack
2
-coated alloy had more cells
2
-coated magnesium alloys subcutane-
2
-coated samples with
2
18 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Figure 1.5 Images of untreated (a, b), phosphate coated (c, d), and MgF2coated (e, f) implants of the alloy Mg-3Zn-0.8Zr after 3 months of implantation in white rabbits. Reprinted with permission from Sun et al. (2013).
this process is safe for human application. For instance, the investigation of the behavior in vivo of magnesium biomedical screws and stents, coated with MgF
,is
2
of particular interest, since these formats are more likely to be implanted than cylinders (most of the in vivo studies used cylinders for the implant). More clinical investigations are also required to further increase the understanding of host response in contact with MgF
-coated magnesium implants.
2
Fluoride conversion coatings for magnesium and its alloys for the biological environment 19
1.4 Conclusions and future trends
The preparation of MgF2coating on magnesium and magnesium alloys is an effec­tive way of improving corrosion resist ance in regular saline solutions, simulated body uids, and in vivo. The most effective method for preparin g thick (and conse­quently more protective) MgF viously preparing the Mg(OH) toxic chemical. The preparation of MgF
coating is by converting Mg(OH)2into MgF2by pre-
2
layer. This method also makes use of HF, which is a
2
coating without HF needs further research
2
to achieve similar corrosion protection properties. The synthesis of nano-sized MgF particles by microwave irradiation of a mixture of magnesium acetate and 1-butyl­3-metylimidazolium tetrauorborate is an interesting method in this regard, but the corrosion protection it renders needs investigation. The short-term instability of the MgF
layer in chlorine solutions needs to be claried in or de r to improve perfor-
2
mance. Nevertheless, tests performed in vivo indicate that, with a proper alloy choice, the MgF
coating provides enough corrosion protection, inhibiting gas cavities f or-
2
mation and inammation related to pH increase. Further tests in vivo are required to assure the safeness of the process, especially with biomedical screws and stent implants.
References
Bakhsheshi-Rad, H., Idris, M. H., Kadir, M. R. A., & Daroonpavar, M. (2013). Effect of uoride
treatment on corrosion behavior of MgCa binary alloy for implant application. Trans- action of Nonferrous Metals Society, 23, 699e710.
Berglundh, T., Abrahamsson, I., Albouy, J. P., & Lindhe, J. (2007). Bone healing at implants
with a uoride-modied surface: an experimental study in dogs. Clinical Oral Implants Research, 18, 147e152.
Booster, J. L., Sandwijk, V., & Reuter, M. A. (2003). Conversion of magnesium uoride to
magnesium hydroxide. Minerals Engineering, 16, 273e281.
Carboneras, M., Garcia-Alonso, M. C., & Escudero, M. L. (2011). Biodegradation kinetics
of modied magnesium-based materials in cell culture medium. Corrosion Science, 53,1433e1439.
Chiu, K. Y., Wong, M. H., Cheng, F. T., & Man, H. C. (2007). Characterization and corrosion
studies of uoride conversion coating on degradable Mg implants. Surface and Coatings Technology, 202, 590e598.
Conceiç~ao, T. F., Scharnagl, N., Blawert, C., Dietzel, W., & Kainer, K. U. (2010). Surface
modication of magnesium alloy AZ31 by hydrouoric acid treatment and its effect on the corrosion behavior. Thin Solid Films, 518, 5209e5218.
Conceiç~ao, T. F., Scharnagl, N., Dietzel, W., & Kainer, K. U. (2011a). Corrosion protection of
magnesium AZ31 alloy using poly(ether imide) [PEI]coatings prepared by the dip coating method: inuence of solvent and substrate pre-treatment. Corrosion Science, 53,338e346.
Conceiç~ao, T. F., Scharnagl, N., Dietzel, W., & Kainer, K. U. (2012). Controlled degradation of
a magnesium alloy in simulated body uid using hydrouoric acid treatment followed by polyacrylonitrile coating. Corrosion Science, 62,83e89.
2
20 Surface Modication of Magnesium and its Alloys for Biomedical Applications
Conceiç~ao, T. F., Scharnagl, N., H€oche, D., Dietzel, W., & Kainer, K. U. (2011b). Study on
the interface of PVDF coatings and HF-treated AZ31 magnesium alloy: determination of interfacial interactions and reactions with self-healing properties. Corrosion Science, 53, 712e719.
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999). Bacterial biolms: a common cause
of persistent infections. Science, 284, 1318e1322.
Cowan, K. G., & Harrison, J. A. (1979). The dissolution of magnesium in Cl
and Fcontaining
aqueous solutions. Electrochimica Acta, 24, 301e308.
Darouiche, R. O. (2004). Treatment of infections associated with surgical implants. The New
England Journal of Medicine, 350, 1422e1429.
Drynda, A., Hassel, T., Hoehn, R., Pery, A., Bach, F., & Peuster, M. (2010). Development and
biocompatibility of a novel corrodible uoride-coated magnesium-calcium alloy with improved degradation kinetics and adequate mechanical properties for cardiovascular applications. Journal of Biomedical Materials Research Part A, 93A, 763e775.
Drynda, A., Seibt, J., Hassel, T., Bach, F., & Peuster, M. (2013). Biocompatibility of uoride-
coated magnesium-calcium alloys with optimized degradation kinetics in a subcutaneous mouse model. Journal of Biomedical Materials Research Part A, 101A,33e43.
Gray, J. E., & Luan, B. (2002). Protective coatings on magnesium and its alloys a critical
review. Journal of Alloys and Compounds, 336,88e113.
Gulbrandsen, E., Tafto, J., & Olsen, A. (1993). The passive behavior of Mg in alkaline uoride
solutions. Electrochemical and electron microscopical investigations. Corrosion Science, 9, 1423e1440.
Hornberger, H., Virtanen, S., & Boccaccini, A. R. (2012). Biomedical coatings on magnesium
alloys e a review. Acta Biomaterialia, 8, 2442e2455.
Jian-Zhong, L., Jiu-gui, H., Yan-wen, T., & Chang-sheng, L. (2009). Corrosion action and
passivation mechanism of magnesium alloy in uoride solution. Transactions of Nonfer- rous Metals Society, 19,50e 54.
Kokubo, T., & Takadama, H. (2006). How useful is SBF in predicting in vivo bone bioactivity?
Biomaterials, 27, 2907e2915.
Lellouche, J., Friedman, A., Lelouche, J., Gedanken, A., & Banin, E. (2012). Improved anti-
bacterial and antibiolm activity of magnesium uoride nanoparticles obtained by water­based ultrasound chemistry. Nanomedicine: Nanotechnology, 8, 702e711.
Lellouche, J., Kahana, E., Elias, S., Gedanken, A., & Banin, E. (2009). Antibiolm activity of
nanosized magnesium uoride. Biomaterials, 30, 5969e5978.
Li, N., Li, Y. D., Wang, Y. B., Li, M., Cheng, Y., Wu, Y. H., et al. (2013). Corrosion resistance
and cytotoxicity of a MgF
coating on biomedical Mge1Ca alloy via vacuum evaporation
2
deposition method. Surface and Interface Analysis, 45, 1217e1222.
Li, Q., Zhong, X., Hu, J., & Kang, W. (2008). Preparation and corrosion resistance studies of
zirconia coating on uorinated AZ91D magnesium alloy. Progress in Organic Coatings, 63, 222e227.
Liu, F., Shan, D., Song, Y., & Han, E. H. (2011). Effect of additives on the properties of plasma
electrolytic oxidation coatings formed on AM50 magnesium alloy in electrolytes con­taining K
ZrF6. Surface and Coatings Technology, 206, 455e463.
2
Ma, Y., Li, N., Li, D., Zhang, M., & Huang, X. (2013). A two-step surface treatment, combining
uoride pretreatment and anodic electrophoresis deposition of waterborne acrylic resin, for MgeLieAleCe alloy. Materials Letters, 90,11e13.
Mao, L., Yuan, G., Niu, J., Zong, Y., & Ding, W. (2013). In vitro degradation behavior and
biocompatibility of MgeNdeZneZr alloy by hydrouoric acid treatment. Materials Science and Engineering: C, 33, 242e250.
Fluoride conversion coatings for magnesium and its alloys for the biological environment 21
Mu, W., & Han, Y. (2008). Characterization and properties of the MgF2/ZrO2composite
coatings on magnesium prepared by micro-arc oxidation. Surface and Coatings Technol- ogy, 202, 4278e4284.
Perales, F., Herrero, J. M., Jaque, D., & Heras, C. (2007). Improvement of MgF
thin coating
2
lms for laser applications. Optical Materials, 29, 783e787.
Pereda, M. D., Alonso, C., Burgos-Asperilla, L., del Valle, J. A., Ruano, O. A., Perez, P., et al.
(2010). Corrosion inhibition of powder metallurgy Mg by uoride treatments. Acta Bio- materialia, 6, 1772e1782.
Prescott, H. A., Li, Z., Kemnitz, E., Deutsch, J., & Lieske, H. (2005). New magnesium oxide
uorides with hydroxy groups as catalysts for Michael additions. Journal of Materials Chemistry, 2005(15), 4616e4628.
Song, G. L., & Atrens, A. (1999). Corrosion mechanisms of magnesium alloys. Advanced
Engineering Materials, 1,11e33.
Sun, J., Wang, J., Jiang, H., Chen, M., Bi, Y., & Liu, D. (2013). In vivo comparative property
study of the bioactivity of coated Mge3Zne0.8Zr alloy. Materials Science and Engi- neering: C, 33, 3263e3272.
Thomann, M., Krause, C., Angrisani, A., Bormann, D., Hassel, T., Windhagen, H., et al. (2009).
Inuence of a magnesium-uoride coating of magnesium-based implants (MgCa0.8) on degradation in a rabbit model. Journal of Biomedical Materials Research Part A, 93,1609e1619.
Verdier, S., Laak, N., Delalande, S., Metson, J., & Dalard, F. (2004). The surface reactivity of a
magnesiumealuminium alloy in acidic uoride solutions studied by electrochemical techniques and XPS. Applied Surface Science, 235, 513e524.
Virtanen, S. (2011). Biodegradable Mg and Mg alloys: corrosion and biocompatibility. Mate-
rials Science and Engineering: B, 176, 1600e1608.
Wagman, D. D., Evans, W. H., Parker, V. B., Schumm, R. H., Halow, I., Bailey, S. M., et al.
(1982). The NBS tables of chemical thermodynamic properties. Selected values for inor­ganic and C1 C2 organic substances in SI units. Journal of Physical and Chemical Reference Data, 11(Suppl. 2), 2-260e2-266.
Witte, F. (2010). The history of biodegradable magnesium implants: a review. Acta Bio-
materialia, 6, 1680e1692.
Witte, F., Fischer, J., Nellesen, J., Vogt, C., Vogt, J., Donath, T., et al. (2010). In vivo corrosion
and corrosion protection of magnesium alloy LAE442. Acta Biomaterialia, 6, 1792e1799.
Wu, L., Dong, J., & Ke, W. (2013). Potentiostatic deposition process of uoride conversion lm
on AZ31 magnesium alloy in 0.1 M KF solution. Electrochimica Acta, 105, 554e559.
Xin-kuan, L., Liu, Z., Liu, P., Xiang, Y., Ku, W., & Ding, W. (2010). Properties of
uoride lm and its effect on electroless nickel deposition on magnesium alloys. Transactions of Nonferrous Metals Society, 20, 2185e2191.
Yan, T., Tan, L., Xiong, D., Liu, X., Zhang, B., & Yang, K. (2010). Fluoride treatment and in
vitro corrosion behavior of an AZ31B magnesium alloy. Materials Science and Engi- neering: C, 30, 740e748.
Phosphate treatment of
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
magnesium alloy implants
2
for biomedical applications
E. Zhang
Key Laboratory of Anisotropy and Texture of Materials, Education Ministry of China, Northeastern University, Shenyang, China
2.1 Introduction
Recently, magnesium and magnesium alloys have attracted much attention as potential biodegradable bone implant materials (Witte et al., 2006, 2005; Xu, Yu, Zhang, Pan, &
Yang, 2007) and stent materials (Erbel et al., 2007) due to their biodegradability in bio-
environment and their excellent mechanical properties such as high strength and an elastic modulus close to that of bone (Staiger, Pietak, Huadmai, & Dias, 2006). More details on the biodegradable magnesium and magnesium alloys have been reviewed elsewhere (Witte, 2010; Zheng, Gu, & Witte, 2014). One of the big problems for the clinical application is their fast corrosion or degradation rate in chloride­containing solutions including human body uid or blood plasma (Song, 2007; Staiger
et al., 2006).
There are several methods that have the potential to reduce the degradation rate or to
improve the corrosion resistance of magnesium alloy in a biological environment:
1. Purication of alloy. Copper, iron, and nickel are the most harmful impurities in magnesium
alloys in that they greatly reduce the corrosion resistance. It was reported that Cu element adversely affects the corrosion resistance of magnesium alloy if present in quantities exceeding 0.05 wt% (Avedesian & Baker, 1999). Iron and nickel also greatly reduce the corrosion resistance when they exceed the upper limit of 0.005 wt% (Avedesian & Baker,
1999).
2. Element alloying. Manganese and zinc are two alloying elements that can improve the corro-
sion resistance of Mg-Al and Mg-Al-Zn alloys by removing iron and other heavy metal elements into relatively harmless intermetallic compound and overcoming the harmful corro­sion effect of iron and nickel impurities, respectively (Avedesian & Baker, 1999). In the ASM system, magnesium-manganese (MA1A alloy) is the only alloy developed for corro­sion resistance (Avedesian & Baker, 1999). In recent years, many alloy systems have been developed for biomedical applications. In our previous studies, Mn and Zn were selected as alloying elements to develop Mg-Mn-Zn alloys due to the good biocompatibility of Mn and Zn (Yin, Zhang, & Zeng, 2008; Zhang, Yin, Xu, Yang, & Yang, 2009). The addition of Mn and Zn improves both the mechanical properties and the corrosion resistance of mag­nesium alloys. It has been shown that the corrosion resistance of Mg-1.0 Mn-1.0 Zn alloy in simulated body uid (SBF) is slightly better than that of WE43 alloy (containing 3.78 wt.% Y,
Surface Modication of Magnesium and its Alloys for Biomedical Applications. http://dx.doi.org/10.1016/B978-1-78242-078-1.00002-5
Copyright © 2015 Elsevier Ltd. All rights reserved.